Gw Pharmaceuticals Plc Asset Turnover Ratio (GWPH), as of first quarter 2021, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Gw Pharmaceuticals Plc  (NASDAQ: GWPH)
 

Gw Pharmaceuticals Plc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Gw Pharmaceuticals Plc asset turnover ratio, the ability of Gw Pharmaceuticals Plc's assets to generate revenue in the first quarter 2021, increased sequentially to 0.76 in the first quarter (Mar 31 2021), GWPH's balance sheet remain strong.

Within sector 78 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the I Quarter 2021, to 2253, from total ranking in the fourth quarter 2020 at 2986.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GWPH Asset Turnover Ratio (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter
Y / Y Asset Change 0.34 % 7.19 % -1.59 % -5.41 % 7.69 %
Y / Y Revenue Change 26.39 % 35.89 % 50.66 % 68.38 % 207.37 %
Asset Turnover Ratio (TTM) 0.76 0.72 0.68 0.61 0.54
GWPH's Total Ranking # 2253 # 2986 # 2985 # 2985 # 2985
Seq. Asset Change -20.37 % 23.84 % 3.31 % -1.5 % -14.94 %
Seq. Revenue Change 2.86 % 8.15 % 12.99 % 0.55 % 10.6 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 79
Healthcare Sector # 292
Overall Market # 2253

Asset Turnover Ratio Statistics
High Average Low
0.56 0.44 0.35
(Sep 30 2020)   (Dec 31 2020)




GWPH Company Profile • Back to GWPH Efficiency Comparisons • Compare GWPH Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2021, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2021 Assets at quarter ending Mar 31 2021
Patterson Companies Inc   2.14 $ 5,912.066  Millions$ 2,759.424  Millions
American Bio Medica Corporation  2.01 $ 3.984  Millions$ 1.981  Millions
Nanomix Corp  1.99 $ 0.148  Millions$ 0.074  Millions
Sunlink Health Systems Inc   1.98 $ 55.844  Millions$ 28.204  Millions
Allied Healthcare Products inc   1.95 $ 37.771  Millions$ 19.360  Millions
Escalon Medical Corp   1.70 $ 9.652  Millions$ 5.688  Millions
Champions Oncology Inc   1.69 $ 41.040  Millions$ 24.231  Millions
Precision Optics Corporation Inc   1.69 $ 10.239  Millions$ 6.063  Millions
Scienture Holdings Inc   1.67 $ 17.972  Millions$ 10.768  Millions
Progyny Inc   1.66 $ 385.967  Millions$ 232.030  Millions
Kewaunee Scientific Corporation  1.65 $ 147.469  Millions$ 89.383  Millions
Alpha Pro Tech Ltd   1.64 $ 107.707  Millions$ 65.623  Millions
Nature s Sunshine Products inc   1.63 $ 391.700  Millions$ 239.919  Millions
Fulgent Genetics Inc   1.51 $ 773.388  Millions$ 510.692  Millions
Co diagnostics Inc   1.51 $ 93.029  Millions$ 61.450  Millions
Chemed Corporation  1.51 $ 2,091.145  Millions$ 1,387.798  Millions
Acura Pharmaceuticals inc  1.49 $ 3.123  Millions$ 2.097  Millions
Vaso Corporation  1.46 $ 69.086  Millions$ 47.202  Millions
Zynex inc   1.46 $ 89.021  Millions$ 61.034  Millions
Encision Inc   1.43 $ 7.538  Millions$ 5.254  Millions
Organogenesis Holdings Inc   1.41 $ 379.118  Millions$ 269.148  Millions
Henry Schein Inc   1.38 $ 10,615.231  Millions$ 7,670.118  Millions
Biotricity Inc   1.37 $ 3.385  Millions$ 2.475  Millions
Procyon Corporation  1.37 $ 4.338  Millions$ 3.176  Millions
Semler Scientific inc   1.36 $ 42.356  Millions$ 31.180  Millions
Retractable Technologies Inc  1.35 $ 120.734  Millions$ 89.410  Millions
Amedisys Inc  1.33 $ 2,116.978  Millions$ 1,597.154  Millions
Idexx Laboratories Inc  1.32 $ 2,858.026  Millions$ 2,157.517  Millions
Mimedx Group Inc   1.30 $ 246.465  Millions$ 189.270  Millions
Vystar Corporation  1.28 $ 27.915  Millions$ 21.800  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.